<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9272807</article-id>
    <article-id pub-id-type="pmid">35640971</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btac371</article-id>
    <article-id pub-id-type="publisher-id">btac371</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Genome Analysis</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CNpare: matching DNA copy number profiles</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3879-454X</contrib-id>
        <name>
          <surname>Chaves-Urbano</surname>
          <given-names>Blas</given-names>
        </name>
        <xref rid="btac371-FM1" ref-type="author-notes"/>
        <aff><institution>Computational Oncology Group, Spanish National Cancer Research Centre (CNIO)</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hernando</surname>
          <given-names>Barbara</given-names>
        </name>
        <xref rid="btac371-FM1" ref-type="author-notes"/>
        <aff><institution>Computational Oncology Group, Spanish National Cancer Research Centre (CNIO)</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Garcia</surname>
          <given-names>Maria J</given-names>
        </name>
        <aff><institution>Computational Oncology Group, Spanish National Cancer Research Centre (CNIO)</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3906-467X</contrib-id>
        <name>
          <surname>Macintyre</surname>
          <given-names>Geoff</given-names>
        </name>
        <xref rid="btac371-cor1" ref-type="corresp"/>
        <aff><institution>Computational Oncology Group, Spanish National Cancer Research Centre (CNIO)</institution>, 28029 Madrid, <country country="ES">Spain</country></aff>
        <!--gmacintyre@cnio.es-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Alkan</surname>
          <given-names>Can</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <fn id="btac371-FM1">
        <p>The authors wish it to be known that, in their opinion, Blas Chaves-Urbano and Barbara Hernando authors should be regarded as Joint Authors.</p>
      </fn>
      <corresp id="btac371-cor1">To whom correspondence should be addressed. Email: <email>gmacintyre@cnio.es</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>15</day>
      <month>7</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-05-31">
      <day>31</day>
      <month>5</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>31</day>
      <month>5</month>
      <year>2022</year>
    </pub-date>
    <volume>38</volume>
    <issue>14</issue>
    <fpage>3638</fpage>
    <lpage>3641</lpage>
    <history>
      <date date-type="received">
        <day>21</day>
        <month>12</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>19</day>
        <month>4</month>
        <year>2022</year>
      </date>
      <date date-type="editorial-decision">
        <day>19</day>
        <month>5</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>27</day>
        <month>5</month>
        <year>2022</year>
      </date>
      <date date-type="corrected-typeset">
        <day>07</day>
        <month>6</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btac371.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Summary</title>
        <p>Selecting the optimal cancer cell line for an experiment can be challenging given the diversity of lines available. Here, we present CNpare, which identifies similar cell line models based on genome-wide DNA copy number.</p>
      </sec>
      <sec id="s2">
        <title>Availability and implementation</title>
        <p>CNpare is available as an R package at <ext-link xlink:href="https://github.com/macintyrelab/CNpare" ext-link-type="uri">https://github.com/macintyrelab/CNpare</ext-link>. All analysis performed in the manuscript can be reproduced via the code found at <ext-link xlink:href="https://github.com/macintyrelab/CNpare_analyses" ext-link-type="uri">https://github.com/macintyrelab/CNpare_analyses</ext-link>.</p>
      </sec>
      <sec id="s4">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Centro Nacional de Investigaciones Oncológicas</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Instituto de Salud Carlos III</institution>
            <institution-id institution-id-type="DOI">10.13039/501100004587</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Spanish Ministry of Science and Innovation</institution>
            <institution-id institution-id-type="DOI">10.13039/501100004837</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>MCIN/AEI/10.13039/501100011033</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Spanish Ministry of Science and Innovation</institution>
            <institution-id institution-id-type="DOI">10.13039/501100004837</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>PID2019-111356RA-I00</award-id>
        <award-id>MCIN/AEI/10.13039/501100011033</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="4"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Immortalized cancer cell lines are an integral part of cancer research and the development of new therapies (<xref rid="btac371-B4" ref-type="bibr">Drost and Clevers, 2018</xref>; <xref rid="btac371-B13" ref-type="bibr">Sharma <italic toggle="yes">et al.</italic>, 2010</xref>). Cell lines are often selected based on their tissue of origin. However, new approaches are available that facilitate appropriate cell line selection based on molecular similarities such as gene expression, DNA methylation and genomics (<xref rid="btac371-B1" ref-type="bibr">Ben-David <italic toggle="yes">et al.</italic>, 2018</xref>; <xref rid="btac371-B2" ref-type="bibr">Dancik <italic toggle="yes">et al.</italic>, 2011</xref>; <xref rid="btac371-B3" ref-type="bibr">Domcke <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btac371-B7" ref-type="bibr">Mohammad <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btac371-B8" ref-type="bibr">Najgebauer <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btac371-B9" ref-type="bibr">Peng <italic toggle="yes">et al.</italic>, 2021</xref>; <xref rid="btac371-B11" ref-type="bibr">Salvadores <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btac371-B14" ref-type="bibr">Sinha <italic toggle="yes">et al.</italic>, 2015</xref>; <xref rid="btac371-B16" ref-type="bibr">Vincent <italic toggle="yes">et al.</italic>, 2015</xref>; <xref rid="btac371-B17" ref-type="bibr">Warren <italic toggle="yes">et al.</italic>, 2021</xref>; <xref rid="btac371-B19" ref-type="bibr">Yu <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btac371-B20" ref-type="bibr">Zhao <italic toggle="yes">et al.</italic>, 2017</xref>). A subset of these approaches perform DNA copy number-based comparison at different resolutions including gene-level copy number, chromosome arm copy number, ploidy or genome doubling status (<xref rid="btac371-B1" ref-type="bibr">Ben-David <italic toggle="yes">et al.</italic>, 2018</xref>; <xref rid="btac371-B3" ref-type="bibr">Domcke <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btac371-B8" ref-type="bibr">Najgebauer <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btac371-B20" ref-type="bibr">Zhao <italic toggle="yes">et al.</italic>, 2017</xref>). However, a specific tool for computing similarity based on genome-wide copy number is lacking. Here, we present CNpare, which identifies similar cell line models based on genome-wide DNA copy number. CNpare compares copy number profiles using four different similarity metrics, quantifies the extent of genome differences between pairs and facilitates comparison based on copy number signatures (<xref rid="btac371-B6" ref-type="bibr">Macintyre <italic toggle="yes">et al.</italic>, 2018</xref>) (<xref rid="btac371-F1" ref-type="fig">Fig. 1A</xref>).</p>
    <fig position="float" id="btac371-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>Overview of CNpare and an example of a cell line match. (<bold>A</bold>) Schematic providing a high-level overview of CNpare’s workflow and computation. The user inputs an absolute copy number profile (left) and CNpare compares this to a precomputed database of cell line copy number from the CCLE and GDSC projects, using a series of different comparison metrics (center). Output is in the form of a list of cell lines ranked based on the strength of match to the input profile. Included in the output is a graphical representation of differences between the genomes and an estimate on the percentage genome difference. (<bold>B</bold>) Example of a CNpare workflow using OVKATE cell line as the input cell line. The top plot shows the copy number profile of the OVKATE ovarian cancer cell line used as input to CNpare. On the left side, the copy number profile of the top hit found using Pearson’s <italic toggle="yes">r</italic> and Manhattan distance is displayed in blue, along with the OVKATE line in red. Underneath the percentage genome difference between the profiles is listed. On the right-hand side, the results of matching the OVKATE cell line based on copy number signatures are displayed, showing the results of clustering all ovarian cancer cell lines based on seven copy number signatures (<xref rid="btac371-B6" ref-type="bibr">Macintyre <italic toggle="yes">et al.</italic>, 2018</xref>). For visualization purposes, the two signatures with the highest variation across cluster means are shown. Each large dot represents the cluster centroid and each small dot represents a cell line. The cluster containing the OVKATE cell line is indicated (A color version of this figure appears in the online version of this article.)</p>
      </caption>
      <graphic xlink:href="btac371f1" position="float"/>
    </fig>
  </sec>
  <sec>
    <title>2 Materials and methods</title>
    <p>CNpare is designed to compare and contrast genome-wide cancer cell line copy number profiles. The user inputs one or more genome-wide absolute copy number profiles in the form of a segment table (chromosome, start, end, copy number) and these are compared to a precomputed database of cancer cell line profiles. This includes profiles of 1170 human cancer cell lines from the Cancer Cell Line Encyclopaedia (CCLE) (<xref rid="btac371-B5" ref-type="bibr">Ghandi <italic toggle="yes">et al.</italic>, 2019</xref>) project and the Genomics of Drug Sensitivity in cancer (GDSC) project (<xref rid="btac371-B18" ref-type="bibr">Yang <italic toggle="yes">et al.</italic>, 2013</xref>). Copy number profiles from these cancer cell lines were generated using ASCAT (<xref rid="btac371-B15" ref-type="bibr">Van Loo <italic toggle="yes">et al.</italic>, 2010</xref>).</p>
    <p>To facilitate comparison between two profiles, <italic toggle="yes">segment tables</italic> are converted to <italic toggle="yes">bin tables</italic> where the copy number is reported for evenly sized bins across the genome (default 500 kb). To adjust for noise at copy number boundaries, a window-based smoothing procedure is used to align boundaries across samples (see <xref rid="sup1" ref-type="supplementary-material">Supplementary Material</xref>).</p>
    <p>Tools that compare genome-wide copy number between tumors from the same patient (<xref rid="btac371-B12" ref-type="bibr">Schwarz <italic toggle="yes">et al.</italic>, 2014</xref>) or cells within a tumor (<xref rid="btac371-B10" ref-type="bibr">Salehi <italic toggle="yes">et al.</italic>, 2021</xref>), rely on evolutionary models. However, tumors from different patients do not have a shared evolutionary relationship, therefore more traditional similarity metrics can be used. Thus, similarity between the bin-level copy number of two profiles is computed using different metrics: Pearson correlation, Manhattan distance, Euclidean distance and Cosine similarity. Depending on the metric used, emphasis can be placed on different properties of the copy number profile (summarized in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). CNpare also computes the percentage genome difference between profiles and provides a visual representation of the differences.</p>
    <p>In addition to direct comparison of copy number profiles, CNpare can also be used to perform comparison using copy number signatures (<xref rid="btac371-B6" ref-type="bibr">Macintyre <italic toggle="yes">et al.</italic>, 2018</xref>). Copy number signatures provide a readout of the different types of chromosomal instability (CIN) that generated the copy number profile. Therefore, this type of comparison allows cell lines to be compared based on the mutational processes present in the sample, rather than the output of these processes. This comparison is also extended to clusters of cell lines with similar patterns of genomic alterations determined via k-means clustering and visualized using the two signatures with the highest variability across clusters.</p>
  </sec>
  <sec>
    <title>3 Results</title>
    <p>We assessed the performance of CNpare in a controlled setting (matching profiles from separate cultures of the same cell lines), and in real-world scenarios (finding the nearest match for cell lines and assessing suitability).</p>
    <sec>
      <title>3.1 Assessing performance using matched cell line cultures</title>
      <p>We used separate cultures of the same cell lines profiled as part of the CCLE and GDSC projects (304 pairs) and observed the ability of CNpare to identify, for each GDSC line, the correctly matched line in the CCLE database (<xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S1</xref>). In 100% of cases, the top hit for each GDSC line was the matched line in the CCLE database. Eighty-seven percent (265 cells) were matched correctly across all similarity metrics, with the remaining 13% being matched correctly only by Pearson correlation and Cosine similarity (not Manhattan and Euclidean distance). For these unmatched cases, the ploidy estimated by ASCAT differed between the CCLE and GDSC cultures, causing comparison based on Manhattan and Euclidean distances to return the wrong cell line. As Pearson correlation and Cosine similarity are normalized measures, they successfully identified the correct profile independent of difference in ploidy status between the cultures. This difference in metric performance demonstrates the choice of metric can determine whether the comparison is ploidy aware or agnostic. As such, we developed a guide on which metrics to use for different circumstances (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>). Similar performance was observed across different bin sizes (<xref rid="sup1" ref-type="supplementary-material">Supplementary Table S2</xref>), even after introducing noise in up to 50% of the copy number profile (<xref rid="sup1" ref-type="supplementary-material">Supplementary Methods</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S2</xref>).</p>
      <p>To compare against alternative approaches, we computed gene-based copy number, chromosome arm-based copy number, ploidy and gene expression for all cell lines in the database. Using these data to compare the cell line culture pairs, we found that gene-based copy number matched 63% of the cell lines correctly, arm-based copy number 91%, ploidy 43% and gene expression 38% (<xref rid="sup1" ref-type="supplementary-material">Supplementary Data S1</xref>). This suggests that high-resolution DNA copy number-based matching provides a robust method of identifying similar cell line models.</p>
    </sec>
    <sec>
      <title>3.2 Assessing performance using real-world scenarios</title>
      <p>For each cell line in the CCLE database, we sought its nearest match using CNpare and observed whether this match was significant (the observed correlation measure was greater than expected by chance) or non-significant (a random match). Using Pearson’s <italic toggle="yes">r</italic>, 93.9% (567/604) of the matched cell lines were significant. Using Manhattan’s distance 41.6% (251/604) were significant. This suggests that a good, ploidy agnostic match can nearly always be found using CNpare; however, the current database only supports good, ploidy aware matches ∼40% of the time.</p>
      <p>We also explored a specific match scenario using the high-grade serous ovarian cancer cell line OVKATE. First, we directly compared the OVKATE copy number profile with copy number profiles in the database. The cell line which had the most similar profile was PANC0203 (Pearson’s <italic toggle="yes">r</italic>= 0.42, p-value = 0.02, with 54.13% genome difference, <xref rid="btac371-F1" ref-type="fig">Fig. 1B</xref>). Despite this line being derived from a pancreatic adenocarcinoma, it showed highly correlated gene expression (Pearson’s <italic toggle="yes">r</italic> = 0.43, p-value = 0.02: <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S3A</xref>) suggesting a robust match. Second, we sought a tissue matched line by comparing copy number signatures. We performed clustering of the OVKATE line with all ovarian cancer cell lines based on copy number signatures using cosine similarity, which allowed us to identify the ovarian cancer cell lines with similar mutational mechanisms regardless of their specific copy number changes. OVKATE clustered with two other ovarian cell lines OVISE and KURAMOCHI (<xref rid="btac371-F1" ref-type="fig">Fig. 1B</xref> and <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S4A</xref> and <xref rid="sup1" ref-type="supplementary-material">B</xref>). These lines both showed correlated gene expression (Pearson‘s <italic toggle="yes">r</italic> = 0.38, p-value = 0.03; and Pearson‘s <italic toggle="yes">r</italic>= 0.48, p-value = 0.01; <xref rid="sup1" ref-type="supplementary-material">Supplementary Fig. S3B</xref> and <xref rid="sup1" ref-type="supplementary-material">C</xref>) suggesting a relevant match in terms of CIN patterns and resulting gene expression changes.</p>
    </sec>
  </sec>
  <sec>
    <title>4 Discussion</title>
    <p>Here, we present CNpare, a cell line copy number profile comparison tool for the purpose of selecting optimal cell line models. CNpare is the first stand-alone tool to facilitate comparison of cell line models based on high-resolution, genome-wide copy number. This complements existing approaches based on low-resolution copy number, gene expression and methylation (<xref rid="btac371-B1" ref-type="bibr">Ben-David <italic toggle="yes">et al.</italic>, 2018</xref>; <xref rid="btac371-B2" ref-type="bibr">Dancik <italic toggle="yes">et al.</italic>, 2011</xref>; <xref rid="btac371-B3" ref-type="bibr">Domcke <italic toggle="yes">et al.</italic>, 2013</xref>; <xref rid="btac371-B7" ref-type="bibr">Mohammad <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btac371-B8" ref-type="bibr">Najgebauer <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btac371-B9" ref-type="bibr">Peng <italic toggle="yes">et al.</italic>, 2021</xref>; <xref rid="btac371-B11" ref-type="bibr">Salvadores <italic toggle="yes">et al.</italic>, 2020</xref>; <xref rid="btac371-B16" ref-type="bibr">Vincent <italic toggle="yes">et al.</italic>, 2015</xref>; <xref rid="btac371-B17" ref-type="bibr">Warren <italic toggle="yes">et al.</italic>, 2021</xref>; <xref rid="btac371-B19" ref-type="bibr">Yu <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btac371-B20" ref-type="bibr">Zhao <italic toggle="yes">et al.</italic>, 2017</xref>). In addition, CNpare offers the option of comparing copy number profiles from a more functional point of view by using copy number signatures.</p>
    <p>CNpare can also be applied to other settings including: quality control—ensuring the sequenced copy number profile of a cell line matches the reference profile; assessing differences between cell line cultures—by estimating the percentage genome difference; and finding the best cell line model for a tumor profile—based on copy number profiles or copy number signatures.</p>
    <p>Despite showing excellent performance during benchmarking, this tool has two key limitations: (i) resolution—comparison is made at 500 kb resolution (default bin size). While it is possible to increase the resolution up to 30 kb, resolution beyond this is limited as the SNP6 technology underpinning the database does not facilitate higher resolution; (ii) total absolute copy number as input. Total absolute copy number is currently required input and performance is dependent on the accuracy of the method used to compute it. We recommend using ASCAT (<xref rid="btac371-B15" ref-type="bibr">Van Loo <italic toggle="yes">et al.</italic>, 2010</xref>) as it matches the method used across the database.</p>
    <p>Despite these limitations (which may be resolved over time as additional data becomes available), our results demonstrate that CNpare can be used to select appropriately matched cancer cell line models, providing a valuable tool for improving cancer research in the context of studying CIN.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btac371_Supplementary_Data</label>
      <media xlink:href="btac371_supplementary_data.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title>Acknowledgements</title>
    <p>The authors would like to thank Philip Smith, Maxime Tarabichi and the Van Loo Lab for providing access to the ASCAT.sc processed CCLE and GDSC copy number profiles.</p>
    <sec>
      <title>Funding</title>
      <p>All authors are hosted by the Centro Nacional de Investigaciones Oncológicas (CNIO), which was supported by the Instituto de Salud Carlos III and recognized as a ‘Severo Ochoa’ Centre of Excellence (ref. CEX2019-000891-S) by the Spanish Ministry of Science and Innovation (MCIN/AEI/10.13039/501100011033). Authors were also supported by a Spanish Ministry of Science and Innovation grant PID2019-111356RA-I00 (MCIN/AEI/10.13039/501100011033).</p>
      <p><italic toggle="yes">Conflict of</italic> <italic toggle="yes">Interest</italic>: G.M., is a founder, director and shareholder of Tailor Bio Ltd, a precision medicine company using copy number signatures for drug discovery and therapy response prediction.</p>
    </sec>
    <sec sec-type="data-availability">
      <title>Data availability</title>
      <p>Precomputed absolute copy number profiles are available at <ext-link xlink:href="https://github.com/VanLoo-lab/ASCAT.sc" ext-link-type="uri">https://github.com/VanLoo-lab/ASCAT.sc</ext-link>. This dataset was derived from SNP6 array data which is available in the CCLE project legacy data (<ext-link xlink:href="https://data.broadinstitute.org/ccle_legacy_data/" ext-link-type="uri">https://data.broadinstitute.org/ccle_legacy_data/</ext-link>) for the CCLE cell lines, and in the EGA Portal (accession number: EGAD00010000644) for the GDSC cell lines. Gene expression data for the CCLE dataset is available in the DepMap Portal at <ext-link xlink:href="https://depmap.org/portal/download/" ext-link-type="uri">https://depmap.org/portal/download/</ext-link>. Gene expression data of cell lines included in both CCLE and GDSC dataset is available in the Cell Model Passports at <ext-link xlink:href="https://cellmodelpassports.sanger.ac.uk/downloads" ext-link-type="uri">https://cellmodelpassports.sanger.ac.uk/downloads</ext-link>. Other data underlying this article are available in the article and the online supplementary material.</p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btac371-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ben-David</surname><given-names>U.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>Genetic and transcriptional evolution alters cancer cell line drug response</article-title>. <source>Nature</source>, <volume>560</volume>, <fpage>325</fpage>–<lpage>330</lpage>.<pub-id pub-id-type="pmid">30089904</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dancik</surname><given-names>G.M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2011</year>) <article-title>A framework to select clinically relevant cancer cell lines for investigation by establishing their molecular similarity with primary human cancers</article-title>. <source>Cancer Res</source>., <volume>71</volume>, <fpage>7398</fpage>–<lpage>7409</lpage>.<pub-id pub-id-type="pmid">22012889</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Domcke</surname><given-names>S.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2013</year>) <article-title>Evaluating cell lines as tumour models by comparison of genomic profiles</article-title>. <source>Nat. Commun</source>., <volume>4</volume>, <fpage>2126</fpage>.<pub-id pub-id-type="pmid">23839242</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Drost</surname><given-names>J.</given-names></string-name>, <string-name><surname>Clevers</surname><given-names>H.</given-names></string-name></person-group> (<year>2018</year>) <article-title>Organoids in cancer research</article-title>. <source>Nat. Rev. Cancer</source>, <volume>18</volume>, <fpage>407</fpage>–<lpage>418</lpage>.<pub-id pub-id-type="pmid">29692415</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B5">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ghandi</surname><given-names>M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>Next-generation characterization of the cancer cell line encyclopedia</article-title>. <source>Nature</source>, <volume>569</volume>, <fpage>503</fpage>–<lpage>508</lpage>.<pub-id pub-id-type="pmid">31068700</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Macintyre</surname><given-names>G.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2018</year>) <article-title>Copy number signatures and mutational processes in ovarian carcinoma</article-title>. <source>Nat. Genet</source>., <volume>50</volume>, <fpage>1262</fpage>–<lpage>1270</lpage>.<pub-id pub-id-type="pmid">30104763</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mohammad</surname><given-names>T.A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>CeL-ID: cell line identification using RNA-seq data</article-title>. <source>BMC Genomics</source>, <volume>20</volume>, <fpage>81</fpage>.<pub-id pub-id-type="pmid">30712511</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Najgebauer</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>CELLector: genomics-guided selection of cancer in vitro models</article-title>. <source>Cell Syst</source>., <volume>10</volume>, <fpage>424</fpage>–<lpage>432.e6</lpage>.<pub-id pub-id-type="pmid">32437684</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peng</surname><given-names>D.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021</year>) <article-title>Evaluating the transcriptional fidelity of cancer models</article-title>. <source>Genome Med</source>., <volume>13</volume>, <fpage>73</fpage>.<pub-id pub-id-type="pmid">33926541</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B10">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Salehi</surname><given-names>S.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021</year>) Cancer phylogenetic tree inference at scale from 1000s of single cell genomes. <italic toggle="yes">bioRxiv</italic>, 2020.05.06.058180.</mixed-citation>
    </ref>
    <ref id="btac371-B11">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Salvadores</surname><given-names>M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2020</year>) <article-title>Matching cell lines with cancer type and subtype of origin via mutational, epigenomic, and transcriptomic patterns</article-title>. <source>Sci. Adv</source>., <volume>6</volume>, <fpage>eaba1862</fpage>.<pub-id pub-id-type="pmid">32937430</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schwarz</surname><given-names>R.F.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2014</year>) <article-title>Phylogenetic quantification of intra-tumour heterogeneity</article-title>. <source>PLoS Comput. Biol</source>., <volume>10</volume>, <fpage>e1003535</fpage>.<pub-id pub-id-type="pmid">24743184</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B13">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sharma</surname><given-names>S.V.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2010</year>) <article-title>Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents</article-title>. <source>Nat. Rev. Cancer</source>, <volume>10</volume>, <fpage>241</fpage>–<lpage>253</lpage>.<pub-id pub-id-type="pmid">20300105</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B14">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Sinha</surname><given-names>R.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021</year>) A pan-cancer survey of cell line tumor similarity by feature-weighted molecular profiles. <italic toggle="yes">Cell Rep. Meth</italic>., <bold>1</bold>, 100039.</mixed-citation>
    </ref>
    <ref id="btac371-B15">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Van Loo</surname><given-names>P.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2010</year>) <article-title>Allele-specific copy number analysis of tumors</article-title>. <source>Proc. Natl. Acad. Sci. USA</source>, <volume>107</volume>, <fpage>16910</fpage>–<lpage>16915</lpage>.<pub-id pub-id-type="pmid">20837533</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B16">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Vincent</surname><given-names>K.M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2015</year>) <article-title>Assessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles</article-title>. <source>Breast Cancer Res</source>., <volume>17</volume>, <fpage>114</fpage>.<pub-id pub-id-type="pmid">26289960</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B17">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Warren</surname><given-names>A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2021</year>) <article-title>Global computational alignment of tumor and cell line transcriptional profiles</article-title>. <source>Nat. Commun</source>., <volume>12</volume>, <fpage>22</fpage>.<pub-id pub-id-type="pmid">33397959</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B18">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>W.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2013</year>) <article-title>Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells</article-title>. <source>Nucleic Acids Res</source>., <volume>41</volume>, <fpage>D955</fpage>–<lpage>D961</lpage>.<pub-id pub-id-type="pmid">23180760</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B19">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>K.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) <article-title>Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types</article-title>. <source>Nat. Commun</source>., <volume>10</volume>, <fpage>3574</fpage>.<pub-id pub-id-type="pmid">31395879</pub-id></mixed-citation>
    </ref>
    <ref id="btac371-B20">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>N.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2017</year>) <article-title>Optimization of cell lines as tumour models by integrating multi-omics data</article-title>. <source>Brief. Bioinformatics</source>, <volume>18</volume>, <fpage>515</fpage>–<lpage>529</lpage>.<pub-id pub-id-type="pmid">27694350</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
